Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


5 J Bone Miner Res
8 Osteoporos Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    J Bone Miner Res

  1. TAI TW, Hwang JS, Li CC, Hsu JC, et al
    The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: A nationwide population study.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4627.
    PubMed         Abstract available

  2. KORHONEN MT, Kujala UM, Kettunen J, Korhonen OV, et al
    Longitudinal associations of high-volume and vigorous-intensity exercise with hip fracture risk in men.
    J Bone Miner Res. 2022 Jun 14. doi: 10.1002/jbmr.4624.
    PubMed         Abstract available

  3. GURUSAMY P, Larsen BA, Allen RT, Ward SR, et al
    Density and Fat Fraction of the Psoas, Paraspinal, and Oblique Muscle Groups are Associated with Lumbar Vertebral Bone Mineral Density in a Multi-Ethnic Community-Living Population: The Multi-Ethnic Study of Atherosclerosis.
    J Bone Miner Res. 2022 Jun 12. doi: 10.1002/jbmr.4634.
    PubMed         Abstract available

  4. LU T, Forgetta V, Greenwood CMT, Richards JB, et al
    Identifying Causes of Fracture Beyond Bone Mineral Density: Evidence from Human Genetics.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4632.
    PubMed         Abstract available

  5. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    The Association of Cold Ambient Temperature with Fracture Risk and Mortality: National data from Norway - A NOREPOS* Study.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4628.
    PubMed         Abstract available

    Osteoporos Int

  6. ZHANG F, Wang Z, Su H, Zhao H, et al
    Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06456.
    PubMed         Abstract available

  7. TALEVSKI J, Sanders KM, Lal A, Watts JJ, et al
    A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06460.
    PubMed         Abstract available

  8. PASKINS Z, Babatunde O, Sturrock A, Toh LS, et al
    Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.
    Osteoporos Int. 2022 Jun 11. pii: 10.1007/s00198-022-06453.
    PubMed         Abstract available

  9. XIAO PL, Cui AY, Hsu CJ, Peng R, et al
    Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 10. pii: 10.1007/s00198-022-06454.
    PubMed         Abstract available

  10. HA J, Kim J, Jeong C, Lim Y, et al
    Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
    Osteoporos Int. 2022;33:1591-1599.
    PubMed         Abstract available

  11. SCHOEB M, Winter EM, Malgo F, Schipper IB, et al
    Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Osteoporos Int. 2022 Mar 21. pii: 10.1007/s00198-022-06368.
    PubMed         Abstract available

  12. FLEHR A, Kallgard J, Alven J, Lagerstrand K, et al
    Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2022 Feb 3. pii: 10.1007/s00198-021-06224.
    PubMed         Abstract available

  13. BAILEY S, Mhango G, Lin JJ
    The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors.
    Osteoporos Int. 2022 Jun 14. pii: 10.1007/s00198-022-06458.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.